| 235 |
Implications of the first edition of the Korean expert consensus-based practice recommendations for transarterial chemoembolization in the management of hepatocellular carcinomaImplications of the first edition of the Korean expert consensus-based practice recommendations for transarterial chemoembolization in the management of hepatocellular carcinoma
Jin Wook ChungJin Wook Chung
KMSID: 1516084057 J Liver Cancer. 2023;23(2):235-237. Published online 2023 July 25 DOI: http://dx.doi.org/10.17998/jlc.2023.06.29 |
|
| 238 |
Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomingsSonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
Sung Won Lee, Min Kyu Kang, Xiang ZhangSung Won Lee, Min Kyu Kang, Xiang Zhang
KMSID: 1516084069 J Liver Cancer. 2023;23(2):238-240. Published online 2023 September 20 DOI: http://dx.doi.org/10.17998/jlc.2023.09.12 |
|
| 241 |
Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer AssociationTransarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul RhimYuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
KMSID: 1516084064 J Liver Cancer. 2023;23(2):241-261. Published online 2023 July 14 DOI: http://dx.doi.org/10.17998/jlc.2023.05.22 |
|
| 262 |
The role of lenvatinib in the era of immunotherapy of hepatocellular carcinomaThe role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
Matthew Man Pok Lee, Landon Long Chan, Stephen Lam ChanMatthew Man Pok Lee, Landon Long Chan, Stephen Lam Chan
KMSID: 1516084055 J Liver Cancer. 2023;23(2):262-271. Published online 2023 August 17 DOI: http://dx.doi.org/10.17998/jlc.2023.07.17 |
|
| 272 |
Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive reviewDiagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review
Woo Kyoung JeongWoo Kyoung Jeong
KMSID: 1516084063 J Liver Cancer. 2023;23(2):272-283. Published online 2023 September 19 DOI: http://dx.doi.org/10.17998/jlc.2023.08.25 |
|
| 284 |
Imaging prognostication and tumor biology in hepatocellular carcinomaImaging prognostication and tumor biology in hepatocellular carcinoma
Diana Kadi, Marilyn F. Yamamoto, Emily C. Lerner, Hanyu Jiang, Kathryn J. Fowler, Mustafa R. BashirDiana Kadi, Marilyn F. Yamamoto, Emily C. Lerner, Hanyu Jiang, Kathryn J. Fowler, Mustafa R. Bashir
KMSID: 1516084066 J Liver Cancer. 2023;23(2):284-299. Published online 2023 September 15 DOI: http://dx.doi.org/10.17998/jlc.2023.08.29 |
|
| 300 |
Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomesManagement of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes
Jae Hyun Yoon, Sung Kyu ChoiJae Hyun Yoon, Sung Kyu Choi
KMSID: 1516084065 J Liver Cancer. 2023;23(2):300-315. Published online 2023 September 21 DOI: http://dx.doi.org/10.17998/jlc.2023.08.27 |
|
| 316 |
A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinomaA multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma
Yu Rim LeeYu Rim Lee
KMSID: 1516084068 J Liver Cancer. 2023;23(2):316-329. Published online 2023 September 22 DOI: http://dx.doi.org/10.17998/jlc.2023.09.04 |
|
| 330 |
Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumabFeasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Tae Hyun Kim, Bo Hyun Kim, Yu Ri Cho, Young-Hwan Koh, Joong-Won ParkTae Hyun Kim, Bo Hyun Kim, Yu Ri Cho, Young-Hwan Koh, Joong-Won Park
KMSID: 1516084062 J Liver Cancer. 2023;23(2):330-340. Published online 2023 May 16 DOI: http://dx.doi.org/10.17998/jlc.2023.04.14 |
|
| 341 |
Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinomaIsolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma
Kyoungdo Mun, Jiwon Han, Pureun Roh, Jonggeun Park, Gahee Kim, Wonhee Hur, Jeongwon Jang, Jongyoung Choi, Seungkew Yoon, Youngkyoung You, Hojoong Choi, Pilsoo SungKyoungdo Mun, Jiwon Han, Pureun Roh, Jonggeun Park, Gahee Kim, Wonhee Hur, Jeongwon Jang, Jongyoung Choi, Seungkew Yoon, Youngkyoung You, Hojoong Choi, Pilsoo Sung
KMSID: 1516084061 J Liver Cancer. 2023;23(2):341-349. Published online 2023 June 12 DOI: http://dx.doi.org/10.17998/jlc.2023.04.30 |
|
| 350 |
Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practiceNomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice
Nalee Kim, Jeong Il Yu, Hee Chul Park, Jung Yong Hong, Ho Yeong Lim, Myung Ji Goh, Yong-Han PaikNalee Kim, Jeong Il Yu, Hee Chul Park, Jung Yong Hong, Ho Yeong Lim, Myung Ji Goh, Yong-Han Paik
KMSID: 1516084059 J Liver Cancer. 2023;23(2):350-361. Published online 2023 September 6 DOI: http://dx.doi.org/10.17998/jlc.2023.08.10 |
|
| 362 |
The efficacy of treatment for hepatocellular carcinoma in elderly patientsThe efficacy of treatment for hepatocellular carcinoma in elderly patients
Han Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young KimHan Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young Kim
KMSID: 1516084058 J Liver Cancer. 2023;23(2):362-376. Published online 2023 September 14 DOI: http://dx.doi.org/10.17998/jlc.2023.08.03 |
|
| 377 |
Clinical outcome of surgical resection for multifocal T2-T3 hepatocellular carcinoma up to 3 nodules: a comparative analysis with a single noduleClinical outcome of surgical resection for multifocal T2-T3 hepatocellular carcinoma up to 3 nodules: a comparative analysis with a single nodule
Sehyeon Yu, Hye-Sung Jo, Young-Dong Yu, Yoo jin Choi, Dong-Sik KimSehyeon Yu, Hye-Sung Jo, Young-Dong Yu, Yoo jin Choi, Dong-Sik Kim
KMSID: 1516084060 J Liver Cancer. 2023;23(2):377-388. Published online 2023 September 15 DOI: http://dx.doi.org/10.17998/jlc.2023.08.24 |
|
| 389 |
Hepatic basidiobolomycosis masquerading as cholangiocarcinoma: a case report and literature reviewHepatic basidiobolomycosis masquerading as cholangiocarcinoma: a case report and literature review
Roopali Sehrawat, Nalini Bansal, Ajitabh Srivastava, Dharmender Malik, Vivek VijRoopali Sehrawat, Nalini Bansal, Ajitabh Srivastava, Dharmender Malik, Vivek Vij
KMSID: 1516084056 J Liver Cancer. 2023;23(2):389-396. Published online 2023 August 17 DOI: http://dx.doi.org/10.17998/jlc.2023.06.07 |
|
| 397 |
A single hepatic mass with two tales: hepatic tuberculosis and hepatocellular carcinomaA single hepatic mass with two tales: hepatic tuberculosis and hepatocellular carcinoma
Yi De Ian Koh, Wei-Qiang LeowYi De Ian Koh, Wei-Qiang Leow
KMSID: 1516084067 J Liver Cancer. 2023;23(2):397-401. Published online 2023 September 8 DOI: http://dx.doi.org/10.17998/jlc.2023.08.30 |
|
| 402 |
Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”
Sun Hyun Bae, Hee Chul ParkSun Hyun Bae, Hee Chul Park
KMSID: 1516084054 J Liver Cancer. 2023;23(2):402-404. Published online 2023 September 8 DOI: http://dx.doi.org/10.17998/jlc.2023.08.18 |
|
